Side Effects and Precautions: Dizziness, increased body temperature, water retention (edema), headache, injection site reactions (e.g., redness, itching), increased hunger, lower blood sugar levels
Specifically, 2-OG has been shown to be an agonist of GPR119, a receptor that plays a key role in promoting GLP-1 release in humans
Obesity Three of the GLP-1 RAs are FDA approved for obesity: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) (these have separate brands for diabetes and obesity, and we have listed the diabetes brand first)
With 3 mL BAC water, 200 mcg equals 6 units - easy to read on a U-100 syringe